This relatively simple finding could have enormous practical implications, some of which might be investigated with the same techniques. For example, there is belief that asthma begets more asthma. To the extent that this is so, would blocking of light-chain kinase prevent the transition from early childhood wheezing to chronic asthma. A trustworthy answer to this question could only be obtained with the clinical gold standard of a placebo-controlled, randomized, double-blind study, but substantial preliminary progress might be made with the same laboratory model used by the authors. Such laboratory experiments might address the very important practical issues of the strength and duration of treatment required to interrupt the progression to chronic asthma. Thus I view the present report as a first installment in what I hope will become a series of studies defining the pathways leading to chronic asthma and strategies for blocking these pathways.
A final point to be made from these observations is that responses described have the characteristics of positive feedback, and there are two general characteristics of positive feedback that may be of particular relevance in the treatment of asthma. The first is that once started, the feedback is self-sustaining, and the second is that the output of the system increases rapidly to its maximum. These considerations suggest a mechanistic explanation for the clinical saw that the treatment of an asthma attack should be sufficiently vigorous to end all symptoms, i.e., to break the feedback loop, and that it should continue until all signs and symptoms of bronchospasm have fully abated.
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